Understanding how immune cells affect cancer treatment in neuroblastoma
Immunoregulatory Mechanisms of BiTE Efficacy in the Cold Neuroblastoma TME
This study is looking at how certain immune cells called regulatory T cells affect the success of a new cancer treatment for neuroblastoma in kids, aiming to find ways to make the treatment work better and help prevent the cancer from coming back.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Seattle Children's Hospital NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11074984 on NIH RePORTER |
What this research studies
This research investigates the role of regulatory T cells in the effectiveness of bispecific T cell engagers (BTEs) for treating neuroblastoma, a type of cancer that primarily affects children. The study aims to understand how these immune cells influence the response of other T cells during BTE therapy, which connects cancer cells to the body's immune system to enhance cancer cell death. By exploring the mechanisms behind T cell exhaustion and the tumor microenvironment, the research seeks to improve treatment outcomes and long-term protection against cancer relapse.
Who could benefit from this research
Good fit: Ideal candidates for this research include children and adults diagnosed with neuroblastoma or acute B-lymphocytic leukemia who are undergoing or considering bispecific T cell engager therapy.
Not a fit: Patients with other types of cancer or those not eligible for bispecific T cell engager therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective immunotherapy treatments for neuroblastoma, improving survival rates and quality of life for patients.
How similar studies have performed: Previous research has shown promising results with bispecific T cell engagers in treating various cancers, indicating a potential for success in this novel application.
Where this research is happening
Seattle, United States
- Seattle Children's Hospital — Seattle, United States (Active)
Researchers
- Principal investigator: Olson, James M — Seattle Children's Hospital
- Study coordinator: Olson, James M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.